| abstract |
Provided in the present invention is a aminopyrimidine heterocyclic compound with adenosine receptor antagonist activity, comprising the compound and pharmaceutically acceptable salts, various isotopes, isomers and crystal structures thereof, of the structure as shown by general formula I. An aminopyrimidine heterocyclic compound with adenosine receptor antagonist activity of the present invention can act as an effective antagonist of the adenosine receptor, and can be used for treating or preventing diseases caused by abnormal adenosine levels. |